Jupiter Topco LLC Makes New Investment in Bath & Body Works, Inc. $BBWI

Key Points

• Jupiter Topco acquired 79,100 shares of Bath & Body Works in the second quarter, valued at approximately $1.83 million. Institutional investors collectively own 95.14% of the company, with several major firms also increasing or initiating positions.
• Bath & Body Works reported quarterly EPS of $0.62, beating estimates of $0.24, while revenue reached $1.51 billion but declined 2.3% year over year. The company issued Q3 and full-year 2026 guidance and announced a quarterly dividend of $0.20 per share, representing a 4.2% yield.
• Wall Street remains cautious, with a consensus “Hold” rating from analysts and an average price target of $22.29. BBWI recently traded at $18.91, below the consensus target.

Jupiter Topco LLC acquired a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 79,100 shares of the company's stock, valued at approximately $1,830,000.

Several other large investors have also recently made changes to their positions in BBWI. BlackRock Inc. bought a new position in Bath & Body Works during the second quarter valued at approximately $449,065,000. AQR Capital Management LLC increased its stake in Bath & Body Works by 132.5% in the 4th quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company's stock worth $229,834,000 after acquiring an additional 6,523,960 shares during the last quarter. Norges Bank bought a new stake in Bath & Body Works in the 4th quarter worth approximately $55,504,000. Balyasny Asset Management L.P. bought a new position in shares of Bath & Body Works during the 4th quarter valued at approximately $54,785,000. Finally, Bank of New York Mellon Corp bought a new stake in Bath & Body Works in the second quarter worth $59,260,000. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Up 2.1%

BBWI stock opened at $18.91 on Friday. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $32.32. The stock has a market capitalization of $3.81 billion, a price-to-earnings ratio of 4.92, a price-to-earnings-growth ratio of 1.92 and a beta of 1.38. The firm's fifty day simple moving average is $20.12 and its two-hundred day simple moving average is $19.83.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The business had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the prior year, the firm posted $0.30 earnings per share. The business's revenue for the quarter was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 2.71 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 4.2%. The ex-dividend date is Friday, August 21st. Bath & Body Works's payout ratio is 20.83%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on BBWI. Robert W. Baird decreased their price target on shares of Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating on the stock in a research note on Thursday, August 27th. Raymond James Financial restated a "market perform" rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Piper Sandler assumed coverage on shares of Bath & Body Works in a research report on Friday, May 15th. They set a "neutral" rating and a $20.00 target price on the stock. Jefferies Financial Group increased their price target on shares of Bath & Body Works from $22.00 to $23.00 and gave the company a "hold" rating in a report on Tuesday, July 28th. Finally, JPMorgan Chase & Co. lifted their price target on Bath & Body Works from $22.00 to $24.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 18th. Four analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $22.29.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source